The Barclays Annual Global Healthcare Conference spotlighted Puma Biotechnology’s advancements in oncology, focusing on innovative cancer treatments. Alan H. Auerbach, Puma’s leader, highlighted the company’s
Category: Healthcare
Exciting Breakthrough for Critically Ill Patients! Major Trial Launch Ahead
Funding Secured for Groundbreaking Trial with SNG001 In a significant development, a new clinical trial is set to begin in the coming months to test
Massive Deal Alert! Johnson & Johnson Makes a Power Move in Psychiatry
Johnson & Johnson’s Bold Acquisition in Neuroscience In a groundbreaking transaction, Johnson & Johnson (J&J) is set to acquire Intra-Cellular Therapies, granting it rights to